Breaking News
Wyeth is now a part of Pfizer Inc. The merger of local Wyeth and Pfizer entities may be pending in various jurisdictions and is subject to completion of various local legal and regulatory obligations. To learn more, please visit www.pfizer.com.

Health Care Professionals Log In

Sign up for TORISEL Updates

Gain access to additional
content on the TORISEL Web
site and receive updates.
You'll also get free, unlimited
access to:

  • The 5 minute Clinical Consult
    2009
  • Epocrates® Online Premium Reference
  • A.D.A.M. QuickSheets
Torisel Banner

TORISEL Interactive Review

Participate in an interactive review of the published TORISEL phase 3 clinical trial:

Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. Hudes G, Carducci M, Tomczak P, et al. N Engl J Med. 2007;356:2271-2281.

TORISEL Interactive Review

Please click here for Important Safety Information
Next: Conferences and Events »

Patient Education Materials

Give your patients and their caregivers information about renal cell carcinoma and TORISEL.

Contact Wyeth About TORISEL

 

242252-01